Penserra Capital Management’s Keros Therapeutics KROS Stock Holding History

Penserra Capital Management’s Portfolio KROS Stock Details KROS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$383K	Buy
2021 Q4	–	Sell
2021 Q3	$21K	Buy
2021 Q2	$22K	Buy
2021 Q1	$32K	Sell
2020 Q4	$37K	Buy